Double-blinding, where neither subjects nor investigators know treatment assignments, is preferred in studies to minimize bias.

“in an Ideal World both the subjects and the investigators should not know who is getting the treatment and who is getting the placebo at a minimum the subjects should not know that would be single blinding but again double blinding is always preferred if possible because the investigators can be biased they can have hidden biases if they know the outcome”